乳房生検市場：製品タイプ、ガイダンス、用途別-2025年～2030年の世界予測

乳房生検市場は、2023年に10億米ドルと評価され、2024年には10億9,000万米ドルに達すると予測され、CAGR 9.26％で成長し、2030年には18億7,000万米ドルになると予測されています。

乳房生検市場の対象範囲には、早期発見と治療計画に不可欠ながん細胞の存在を判定するために、乳房から組織または液体を採取する診断手順が含まれます。マンモグラフィに異常のある患者や触知可能なしこりのある患者に広く適用されます。主なエンドユーザーは、病院、診断センター、外来手術センターなどです。乳がん罹患率の上昇、早期診断に関する意識の高まり、侵襲性の低い手技に対する需要の高まりが、その必要性を後押ししています。市場成長に影響を与える要因としては、真空支援法や画像誘導法などの生検器具の技術進歩があり、これらは精度を高め、手技の不快感を軽減します。乳がんの罹患率の増加や早期診断を促進する政府の取り組みが市場拡大をさらに後押ししています。現在のビジネスチャンスは、ヘルスケアインフラが改善しつつある新興市場にあり、市場浸透のための肥沃な土壌を提供しています。企業は、AI支援画像解析やより患者に優しい生検プロトコルなどのイノベーションを活用して、精度と患者体験を向上させることができます。課題には、高い手術費用、手術への不安による患者の消極的な姿勢、偽陽性や偽陰性につながる生検結果の不一致などがあります。どんな新技術も厳格な安全性と有効性の基準に準拠しなければならないため、規制上のハードルを乗り越えることがさらなる課題となります。持続可能な成長のためには、企業は費用対効果の高いソリューションの開発と、技術的進歩による手技精度の向上に注力すべきです。より低侵襲な技術、画像診断モダリティの改善、予測診断のためのAIの統合に関する調査は、競争上の優位性をもたらす可能性があります。さらに、個人の遺伝子プロファイルに合わせた個別化乳がん診断ツールは、今後の技術革新の有望分野です。市場競争は中程度であり、主要企業は競争力を獲得するために研究開発に継続的に投資しています。ヘルスケアプロバイダーとの連携を促進し、専門家や患者の教育に投資する企業が大きな市場シェアを獲得し、将来の市場力学を牽引する可能性が高いです。

市場力学：急速に進化する乳房生検市場の主要市場インサイトを公開

乳房生検市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の乳がん罹患率の上昇
  • 乳がんに対する認識と治療に対する政府の取り組み
  • 乳がんの早期発見とスクリーニングに対する嗜好の変化
• 市場抑制要因
  • 高コストと時間のかかる検査
• 市場機会
  • リキッドバイオプシーの出現と有望な臨床試験
  • 乳がん治療の研究開発への投資と資金の増加
• 市場の課題
  • 生検針による感染の可能性

ポーターの5つの力：乳房生検市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：乳房生検市場における外部からの影響の把握

外部マクロ環境要因は、乳房生検市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析乳房生検市場における競合情勢の把握

乳房生検市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス乳房生検市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、乳房生検市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨乳房生検市場における成功への道筋を描く

乳房生検市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で乳がん罹患率が上昇
    • 乳がんの啓発と治療のための政府の取り組み
    • 乳がんの早期発見とスクリーニングに対する好みの変化
  • 抑制要因
    • コストが高く時間のかかる手続き
  • 機会
    • 液体生検の出現と有望な臨床試験
    • 乳がん治療の研究開発への投資と資金の増加
  • 課題
    • 生検針に関連する感染の可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 乳房生検市場：製品別

• アッセイキット
• 生検針
• 生検テーブル
• 誘導システム
• 液体生検器具
• ローカリゼーションワイヤー

第7章 乳房生検市場：タイプ別

• リキッド乳房生検
  • 循環腫瘍細胞
  • 循環腫瘍DNA
• ニードル乳房生検
  • コア針生検
  • 穿刺吸引細胞診
  • 吸引補助生検
• オープンサージカル乳房生検
  • 切除
  • 切開

第8章 乳房生検市場：ガイダンス別

• 画像誘導生検
  • マンモグラフィー誘導定位生検
  • MRIガイド下生検
  • 超音波ガイド下生検
• 液体生検
  • マイクロアレイベースの生検
  • NGSベースの生検
  • PCRベースの生検

第9章 乳房生検市場：用途別

• 早期がん検診
• 再発モニタリング
• 治療法の選択
• 治療モニタリング

第10章 南北アメリカの乳房生検市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の乳房生検市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの乳房生検市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • クエスト・ダイアグノスティクスがヘイスタック・オンコロジーを買収、腫瘍学ポートフォリオに個別化がん治療の改善に向けた高感度液体生検技術を追加
  • ガーダントヘルス、ER+、HER2-進行性または転移性乳がんにおけるESR1変異患者の治療を目的としたメナリニグループのORSERDUのコンパニオン診断薬としてGuardant360 CDxのFDA承認を取得
  • TransMed7 LLC、SpeedBird乳房生検デバイスを商業的に発売するための最初の臨床使用を発表
• 戦略分析と提言

企業一覧

• Argon Medical
• Becton, Dickinson, and Company
• Bio-Rad Laboratories, Inc
• Biocept, Inc.
• Cook Group Incorporated
• CooperSurgical, Inc.
• F. Hoffmann-La Roche Ltd.
• Fluxion Biosciences Inc.
• FUJIFILM Corporation
• GE HealthCare
• Guardant Health
• Halma plc
• Hologic, Inc.
• Illumina, Inc.
• INRAD, Inc.
• Iskus Health Ltd.
• Johnson & Johnson Services, Inc.
• Leica Biosystems Nussloch GmbH
• Medtronic PLC
• Merit Medical Systems
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• TransMed7, LLC
• Trivitron Healthcare

LIST OF FIGURES

• FIGURE 1. BREAST BIOPSY MARKET RESEARCH PROCESS
• FIGURE 2. BREAST BIOPSY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BREAST BIOPSY MARKET DYNAMICS
• TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. CANADA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CANADA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 75. CANADA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 76. CANADA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 77. CANADA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 78. CANADA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 79. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 80. CANADA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. CHINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. CHINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 122. CHINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 123. CHINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 124. CHINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 125. CHINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 126. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 127. CHINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. INDIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. INDIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 131. INDIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 132. INDIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 133. INDIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 134. INDIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 135. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 136. INDIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SINGAPORE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. TAIWAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. THAILAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. VIETNAM BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. DENMARK BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. EGYPT BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. FINLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. FRANCE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. GERMANY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. ISRAEL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. ITALY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. ITALY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 284. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 285. ITALY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 286. ITALY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 287. ITALY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 288. ITALY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 289. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 290. ITALY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 291. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 292. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 298. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 299. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. NIGERIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 301. NIGERIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 307. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 308. NIGERIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. NORWAY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 310. NORWAY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 311. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 312. NORWAY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 314. NORWAY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 316. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 317. NORWAY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 318. POLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 319. POLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 320. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 321. POLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 322. POLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 323. POLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 324. POLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 325. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 326. POLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 327. QATAR BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 328. QATAR BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 329. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 330. QATAR BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 331. QATAR BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 332. QATAR BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 333. QATAR BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 334. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 335. QATAR BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 336. RUSSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 337. RUSSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 338. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 339. RUSSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 340. RUSSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 341. RUSSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 342. RUSSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 343. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 344. RUSSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 345. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 346. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 347. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 348. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 349. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 350. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 351. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 352. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
• TABLE 353. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 354. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 355. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 356. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 357. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 358. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 359. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 360. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 361. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID

The Breast Biopsy Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.09 billion in 2024, and is projected to grow at a CAGR of 9.26%, to USD 1.87 billion by 2030.

The scope of the breast biopsy market encompasses diagnostic procedures to extract tissue or fluid from the breast to determine the presence of cancerous cells, vital for early detection and treatment planning. It widely applies to patients with abnormal mammograms or palpable lumps. The key end-users include hospitals, diagnostic centers, and ambulatory surgical centers. The necessity is driven by rising breast cancer incidences, growing awareness regarding early diagnosis, and increased demand for less invasive procedures. Factors influencing market growth include technological advancements in biopsy instruments such as vacuum-assisted and image-guided methods, which enhance accuracy and reduce procedural discomfort. The increasing incidence of breast cancer and government initiatives promoting early diagnosis further bolster market expansion. Current opportunities lie in emerging markets with improving healthcare infrastructure, offering a fertile ground for market penetration. Businesses could leverage innovations such as AI-assisted image analysis and more patient-friendly biopsy protocols to enhance accuracy and patient experience. Challenges include high procedural costs, patient reluctance due to surgical anxiety, and discrepancies in biopsy results leading to false positives or negatives. Navigating regulatory hurdles poses an additional challenge, as any new technology must comply with stringent safety and efficacy standards. For sustainable growth, firms should focus on developing cost-effective solutions and enhancing procedural accuracy through technological advancements. Research into less invasive techniques, improved imaging modalities, and integrating AI for predictive diagnostics could provide competitive advantages. Moreover, personalized breast cancer diagnosis tools tailored to individual genetic profiles represent a promising area for future innovation. The market is moderately competitive, with key players continuously investing in research and development to gain a competitive edge. Companies that foster collaborations with healthcare providers and invest in educating professionals and patients are likely to capture significant market share and drive future market dynamics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Biopsy Market

The Breast Biopsy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of breast cancer worldwide
  • Government initiative for awareness and treatment of breast cancer
  • Shifting preferences for early detection and screening for breast cancer
• Market Restraints
  • High-cost and time consuming procedure
• Market Opportunities
  • Emergence of liquid biopsy and promising clinical trials
  • Increasing investments and funding for R&D of breast cancer treatment
• Market Challenges
  • Possibilities of infection associated with biopsy needles

Porter's Five Forces: A Strategic Tool for Navigating the Breast Biopsy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Biopsy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Biopsy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Biopsy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Biopsy Market

A detailed market share analysis in the Breast Biopsy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Biopsy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Biopsy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Biopsy Market

A strategic analysis of the Breast Biopsy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Market, highlighting leading vendors and their innovative profiles. These include Argon Medical, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, Biocept, Inc., Cook Group Incorporated, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc., FUJIFILM Corporation, GE HealthCare, Guardant Health, Halma plc, Hologic, Inc., Illumina, Inc., INRAD, Inc., Iskus Health Ltd., Johnson & Johnson Services, Inc., Leica Biosystems Nussloch GmbH, Medtronic PLC, Merit Medical Systems, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., TransMed7, LLC, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Assay Kits, Biopsy Needles, Biopsy Tables, Guidance Systems, Liquid Biopsy Instruments, and Localization Wires.
• Based on Type, market is studied across Liquid Breast Biopsy, Needle Breast Biopsy, and Open Surgical Breast Biopsy. The Liquid Breast Biopsy is further studied across Circulating Tumor Cells and Circulating Tumor DNA. The Needle Breast Biopsy is further studied across Core Needle Biopsy, Fine Needle Aspiration Biopsy, and Vacuum-Assisted Biopsy. The Open Surgical Breast Biopsy is further studied across Excisional and Incisional.
• Based on Guidance, market is studied across Image-Guided Biopsy and Liquid Biopsy. The Image-Guided Biopsy is further studied across Mammography-Guided Stereotactic Biopsy, MRI Guided Biopsy, and Ultrasound-Guided Biopsy. The Liquid Biopsy is further studied across Microarray-Based Biopsy, NGS-Based Biopsy, and PCR-Based Biopsy.
• Based on Application, market is studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of breast cancer worldwide
    • 5.1.1.2. Government initiative for awareness and treatment of breast cancer
    • 5.1.1.3. Shifting preferences for early detection and screening for breast cancer
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost and time consuming procedure
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of liquid biopsy and promising clinical trials
    • 5.1.3.2. Increasing investments and funding for R&D of breast cancer treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Possibilities of infection associated with biopsy needles
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Breast Biopsy Market, by Product

• 6.1. Introduction
• 6.2. Assay Kits
• 6.3. Biopsy Needles
• 6.4. Biopsy Tables
• 6.5. Guidance Systems
• 6.6. Liquid Biopsy Instruments
• 6.7. Localization Wires

7. Breast Biopsy Market, by Type

• 7.1. Introduction
• 7.2. Liquid Breast Biopsy
  • 7.2.1. Circulating Tumor Cells
  • 7.2.2. Circulating Tumor DNA
• 7.3. Needle Breast Biopsy
  • 7.3.1. Core Needle Biopsy
  • 7.3.2. Fine Needle Aspiration Biopsy
  • 7.3.3. Vacuum-Assisted Biopsy
• 7.4. Open Surgical Breast Biopsy
  • 7.4.1. Excisional
  • 7.4.2. Incisional

8. Breast Biopsy Market, by Guidance

• 8.1. Introduction
• 8.2. Image-Guided Biopsy
  • 8.2.1. Mammography-Guided Stereotactic Biopsy
  • 8.2.2. MRI Guided Biopsy
  • 8.2.3. Ultrasound-Guided Biopsy
• 8.3. Liquid Biopsy
  • 8.3.1. Microarray-Based Biopsy
  • 8.3.2. NGS-Based Biopsy
  • 8.3.3. PCR-Based Biopsy

9. Breast Biopsy Market, by Application

• 9.1. Introduction
• 9.2. Early Cancer Screening
• 9.3. Recurrence Monitoring
• 9.4. Therapy Selection
• 9.5. Treatment Monitoring

10. Americas Breast Biopsy Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Breast Biopsy Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Breast Biopsy Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
  • 13.3.2. Guardant Health Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for Menarini Group's ORSERDU for the Treatment of Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
  • 13.3.3. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argon Medical
• 2. Becton, Dickinson, and Company
• 3. Bio-Rad Laboratories, Inc
• 4. Biocept, Inc.
• 5. Cook Group Incorporated
• 6. CooperSurgical, Inc.
• 7. F. Hoffmann-La Roche Ltd.
• 8. Fluxion Biosciences Inc.
• 9. FUJIFILM Corporation
• 10. GE HealthCare
• 11. Guardant Health
• 12. Halma plc
• 13. Hologic, Inc.
• 14. Illumina, Inc.
• 15. INRAD, Inc.
• 16. Iskus Health Ltd.
• 17. Johnson & Johnson Services, Inc.
• 18. Leica Biosystems Nussloch GmbH
• 19. Medtronic PLC
• 20. Merit Medical Systems
• 21. Siemens Healthineers
• 22. Sysmex Corporation
• 23. Thermo Fisher Scientific Inc.
• 24. TransMed7, LLC
• 25. Trivitron Healthcare